NCT06603857View on ClinicalTrials.gov

Skin Care Regimen for Improving Photoaging Signs on the Face

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions
Improve Photoaging Signs
Interventions
DRUG

CE Ferulic

CE Ferulic serum regimen combined with laser treatment

DRUG

Sham Comparator

Vehicle serum regimen combined with laser treatment

DEVICE

1927nm (Clear and Brilliant Perméa®)

non-ablative fractional diode laser

Trial Locations (1)

92121

West Dermatology Research Center, San Diego

All Listed Sponsors
collaborator

L'Oreal

INDUSTRY

lead

Goldman, Butterwick, Fitzpatrick and Groff

OTHER

NCT06603857 - Skin Care Regimen for Improving Photoaging Signs on the Face | Biotech Hunter | Biotech Hunter